Evidence map›Paper›PMID 34960227›Full record

ReviewVaccines2021

Optimising COVID-19 Vaccination Policy to Mitigate SARS-CoV-2 Transmission within Schools in Zimbabwe.

Grant Murewanhema, Solomon Mukwenha, Tafadzwa Dzinamarira, Zindoga Mukandavire, Diego Cuadros, Roda Madziva, Innocent Chingombe, Munyaradzi Mapingure, Helena Herrera, Godfrey Musuka

Abstract readReview
In one paragraph

Review in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Grant MurewanhemaUnit of Obstetrics and Gynecology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.ORCID 0000-0001-7531-730X
Solomon MukwenhaICAP at Columbia University, Harare, Zimbabwe.
Tafadzwa DzinamariraICAP at Columbia University, Harare, Zimbabwe.
Zindoga MukandavireCenter for Data Science and Artificial Intelligence, Emirates Aviation University, Dubai P.O. Box 53044, United Arab Emirates.
Diego CuadrosDepartment of Geography and Geographic Information Science, University of Cincinnati, Cincinnati, OH 45221, USA.
Roda MadzivaSchool of Sociology and Social Policy, University of Nottingham, Nottingham NG7 2RD, UK.
Innocent ChingombeICAP at Columbia University, Harare, Zimbabwe.
Munyaradzi MapingureICAP at Columbia University, Harare, Zimbabwe.
Helena HerreraSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2UP, UK.ORCID 0000-0003-0107-8128
Godfrey MusukaICAP at Columbia University, Harare, Zimbabwe.ORCID 0000-0001-9077-4429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has disrupted the learning of millions of children across the world. Since March 2020 when the first cases of COVID-19 were reported in Zimbabwe, the country, like many others, has gone through periods of closing and re-opening of schools as part of the national COVID-19 control and mitigation measures. Schools promote the social, mental, physical, and moral development of children. With this viewpoint, the authors argue that schools should not be closed to provide a measured and efficient response to the threats posed by the COVID-19 epidemic. Rather, infection prevention and control strategies, including vaccination of learners and teachers, and surveillance in schools should be heightened. The use of multiple prevention strategies discussed in this viewpoint has shown that when outbreaks in school settings are adequately managed, the transmission usually is low. The information presented here suggests that schools should remain open due to the preponderance of evidence indicating the overriding positive impacts of this policy on the health, development, and wellbeing of children.

Indexed as

COVID-19schoolsvaccinationZimbabwe

Identifiers

PMID34960227
PMCPMC8709186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.